Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity.
Matthew P KleinHalis Kaan AkturkJanet K Snell-BergeonViral N ShahPublished in: Journal of diabetes science and technology (2024)
This article has been temporarily removed for correction.